Axogen (AXGN) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.34% |
| Dec 31, 2025 | 16.32% |
| Sep 30, 2025 | 17.93% |
| Mar 31, 2025 | 32.94% |
| Dec 31, 2024 | 41.57% |
| Sep 30, 2024 | 48.97% |
| Jun 30, 2024 | 54.81% |
| Mar 31, 2024 | 57.17% |
| Dec 31, 2023 | 61.65% |
| Sep 30, 2023 | 63.27% |
| Jun 30, 2023 | 103.99% |
| Mar 31, 2023 | 103.54% |
| Dec 31, 2022 | 104.87% |
| Sep 30, 2022 | 111.62% |
| Jun 30, 2022 | 112.37% |
| Mar 31, 2022 | 114.22% |
| Dec 31, 2021 | 111.29% |
| Sep 30, 2021 | 111.83% |
| Jun 30, 2021 | 109.58% |
| Mar 31, 2021 | 102.78% |
| Dec 31, 2020 | 108.66% |
| Sep 30, 2020 | 112.67% |
| Mar 31, 2020 | 102.90% |
| Dec 31, 2019 | 88.89% |
| Sep 30, 2019 | 80.27% |
| Jun 30, 2019 | 74.83% |
| Mar 31, 2019 | 75.94% |
| Dec 31, 2018 | 83.95% |
| Sep 30, 2018 | 131.97% |
| Jun 30, 2018 | 86.06% |
| Mar 31, 2018 | 84.43% |
| Dec 31, 2017 | 82.50% |
| Sep 30, 2017 | 66.14% |
| Jun 30, 2017 | 56.15% |
| Mar 31, 2017 | 46.30% |
| Dec 31, 2016 | 43.24% |
| Sep 30, 2016 | 35.08% |
| Jun 30, 2016 | 251.22% |
| Dec 31, 2015 | 14.16% |